ECO Animal Health participating at Animal Health, Nutrition and Technology Innovation summit

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be participating at the Animal Health, Nutrition and Technology Innovation summit and leading the round table discussion on swine disease management.

Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier innovation summit, showcasing the emerging companies and connecting them with investors and strategic partners. The summit engages all key participants in the value chain so it can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.

Please find further information on the event at https://kisacoresearch.com/events/animal-health-europe-2023

ECO Animal Health Group plc (LON EAH) researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development for new products, particularly vaccines, and seeking to in-license new products.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
ECO Animal Health Group plc

More articles like this

ECO Animal Health Group plc

ECO Animal Health ECOVAXXIN® trademark approved by the EU

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced that the ECOVAXXIN® trademark has been approved by the European

ECO Animal Health Group plc

ECO Animal Health completes sale of freehold properties

ECO Animal Health Group plc (LON:EAH) has announced that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey.  This was the former registered office of the Company and following

ECO Animal Health Group plc

ECO Animal Health to host two Capital Markets events

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and

ECO Animal Health Group plc

ECO Animal Health Group Retail Investor Presentation

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will be hosting a Capital Markets Day presentation for retail investors focusing on progress

ECO Animal Health Group plc

ECO Animal Health AGM to be held on Thursday 7 September 2023

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that the Company is today posting to shareholders notice of the Company’s Annual

ECO Animal Health Group plc

ECO Animal Health Group revenue ahead of market expectations

ECO Animal Health Group plc (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial ·      Revenue and adjusted EBITDA ahead of market expectations ·      Group sales increased by 4% to £85.3m, driven primarily